Clinical Trials · NCT01782261
Incretin Effect on the Immunological Phenotype
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Medical University of Graz
- Enrollment
- 15
- Start date
- Feb 2012
- Locations
- 1 site, Austria
- Primary endpoint
- Increase of regulatory FOXP3+ T cells